Custodio, Alberto .

HRN: 19-38-61  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/06/2024
09/14/2024
IV
2.25gm
Q6H
Infected Wound
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  PneumoniaSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: